Cover storyFDA’s Proposed DTC Rule Could End TV Drug Ads
FDA’s Proposed DTC Rule would remove the adequate provision option for broadcast drug ads, requiring full risk information in every spot. See what pharma leaders can do now.
Cover storyFDA’s Proposed DTC Rule would remove the adequate provision option for broadcast drug ads, requiring full risk information in every spot. See what pharma leaders can do now.

FDA CBER rejects Dr. Fallon's CAPA response as insufficient, requiring a fully implemented plan before any future clinical trial participation.

FDA issues CRL for Capricor's deramiocel BLA, citing irreparable data integrity violations in Study HOPE-3 that no post-hoc amendment could resolve.

FDA's updated verified clinical benefit list covers 14 non-malignant and neurological AA conversions, offering regulatory teams concrete timeline benchmarks.

AbbVie commits $217M to AI-integrated biologics manufacturing at Barceloneta, Puerto Rico, targeting full operations by 2030.
Latest edition
SPONSORED
SPONSORED
SPONSORED
Nov 23
Nov 28
Dec 03From native content to event partnerships, we help brands earn the attention of a hard-to-reach, senior audience — without breaking the reading experience.
See partnership options →Explore expert-led guides crafted for pharma professionals. Log in to download and stay ahead.







Join thousands of pharma professionals getting our sharpest reporting, briefings and guides — free.

